Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter September 21, 2020

High dose vs. low dose oxytocin for labor augmentation: a systematic review and meta-analysis of randomized controlled trials

  • Rehab Abdelhamid Aboshama , Ahmed Mohamed Abdelhakim ORCID logo EMAIL logo , Mohammad Abrar Shareef , Abdulhadi A. AlAmodi , Mohammad Sunoqrot , Nourhan M. Alborno , Mohamed Gadelkarim , Ahmed M. Abbas and Mohamed Sobhy Bakry

Abstract

Objectives

To compare the safety and efficacy between high dose and low dose oxytocin administration for labor augmentation.

Methods

We searched for the available studies during March 2020 in PubMed, Cochrane Library, Scopus, and ISI Web of science. All randomized clinical trials (RCTs) that assessed safety and efficacy of high dose vs. low dose oxytocin for labor augmentation were considered. The extracted data were entered into RevMan software. Dichotomous and continuous data were pooled as odds ratio (OR) and mean difference (MD) respectively, with the corresponding 95% confidence intervals (CI). Our main outcomes were cesarean delivery rate, spontaneous vaginal delivery rate, uterine hyperstimulation and tachysystole, and labor duration from oxytocin infusion.

Results

Eight RCTs with 3,154 patients were included. High dose oxytocin did not reduce cesarean delivery rate compared to low dose oxytocin (OR=0.76, 95% CI [0.52, 1.10], p=0.15). After solving the reported heterogeneity, high dose oxytocin did not increase the rate of spontaneous vaginal deliveries vs. low dose oxytocin (OR=1.06, 95% CI [0.84, 1.32], p=0.64). Low dose oxytocin was linked to a significant decline in uterine hyperstimulation and tachysystole (p>0.001). A reduction in labor duration was found in high dose oxytocin group over low oxytocin regimen (MD=−1.02 h, 95% CI [−1.77, −0.27], p=0.008).

Conclusions

We found no advantages for high dose oxytocin over low dose oxytocin in labor augmentation except in reducing labor duration. Low dose oxytocin is safer as it decreases the incidence of uterine hyperstimulation and tachysystole. More trials are needed to confirm our findings.


Corresponding author: Ahmed Mohamed Abdelhakim, Cairo University, Kasr Alainy, Faculty of Medicine, 395 Portsaid Street, Bab el-kalq, Cairo, 11638, Egypt, E-mail:

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Ethical approval: The local Institutional Review Board deemed the study exempt from review.

References

1. Karaçam, Z, Walsh, D, Bugg, GJ. Evolving understanding and treatment of labour dystocia. Eur J Obstet Gynecol Reprod Biol 2014;182:123–7. https://doi.org/10.1016/j.ejogrb.2014.09.011.Search in Google Scholar

2. Kanwar, S, Rabindran, R, Lindow, SW. Delivery outcomes after day and night onset of labour. J Perinat Med 2015;43:729–33. https://doi.org/10.1515/jpm-2014-0241.Search in Google Scholar

3. Kernberg, A, Caughey, AB. Augmentation of labor: a review of oxytocin augmentation and active management of labor. Obstet Gynecol Clin N Am 2017;44:593–600. https://doi.org/10.1016/j.ogc.2017.08.012.Search in Google Scholar

4. Gross, MM, Petersen, A, Hille, U, Hillemanns, P. Association between women’s self-diagnosis of labor and labor duration after admission. J Perinat Med 2010;38:33–8. https://doi.org/10.1515/jpm.2010.005.Search in Google Scholar

5. Bell, AF, Erickson, EN, Carter, CS. Beyond labor: the role of natural and synthetic oxytocin in the transition to motherhood. J Midwifery Womens Health 2014;59:35–42. https://doi.org/10.1111/jmwh.12101.Search in Google Scholar

6. Zhang, J, Branch, DW, Ramirez, MM, Laughon, SK, Reddy, U, Hoffman, M, et al. Oxytocin regimen for labor augmentation, labor progression, perinatal outcomes. Obstet Gynecol 2011;118:249–56. https://doi.org/10.1097/aog.0b013e3182220192.Search in Google Scholar

7. Burguet, A, Rousseau, A. Oxytocin administration during spontaneous labor: guidelines for clinical practice. Chapter 6: fetal, neonatal and pediatric risks and adverse effects of using oxytocin augmentation during spontaneous labor. J Gynecol Obstet Hum Reprod 2017;46:523–30. https://doi.org/10.1016/j.jogoh.2017.04.012.Search in Google Scholar

8. Belghiti, J, Kayem, G, Dupont, C, Rudigoz, R-C, Bouvier-Colle, M-H, Deneux-Tharaux, C. Oxytocin during labour and risk of severe postpartum haemorrhage: a population-based, cohort-nested case–control study. BMJ Open 2011;1:e000514. https://doi.org/10.1136/bmjopen-2011-000514.Search in Google Scholar

9. Mori, R, Tokumasu, H, Pledge, D, Kenyon, S. High dose versus low dose oxytocin for augmentation of delayed labour. Cochrane Database Syst Rev 2011;CD007201. https://doi.org/10.1002/14651858.CD007201.pub2.Search in Google Scholar

10. Xenakis, EM-J, Langer, O, Piper, JM, Conway, D, Berkus, MD. Low-dose versus high-dose oxytocin augmentation of labor — a randomized trial. Am J Obstet Gynecol 1995;173:1874–8. https://doi.org/10.1016/0002-9378(95)90444-1.Search in Google Scholar

11. Selin, L, Wennerholm, U-B, Jonsson, M, Dencker, A, Wallin, G, Wiberg-Itzel, E, et al. High-dose versus low-dose of oxytocin for labour augmentation: a randomised controlled trial. Women Birth 2019;32:356–63. https://doi.org/10.1016/j.wombi.2018.09.002.Search in Google Scholar PubMed

12. Higgins, JPT, Green, S. Cochrane handbook for systematic reviews of interventions. Chichester, UK: John Wiley & Sons; 2011.Search in Google Scholar

13. Moher, D, Liberati, A, Tetzlaff, J, Altman, DJ. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097. https://doi.org/10.1371/journal.pmed.1000097.Search in Google Scholar PubMed PubMed Central

14. Kenyon, S, Tokumasu, H, Dowswell, T, Pledge, D, Mori, R. High-dose versus low-dose oxytocin for augmentation of delayed labour. Cochrane Database Syst Rev 2013;CD007201. https://doi.org/10.1002/14651858.CD007201.pub3.Search in Google Scholar PubMed

15. Briggs, GG, Wan, SR. Drug therapy during labor and delivery, part 2. Am J Health-Syst Pharm AJHP Off J Am Soc Health-Syst Pharm 2006;63:1131–9. https://doi.org/10.2146/ajhp050265.p2.Search in Google Scholar PubMed

16. Stewart, RD, Bleich, AT, Lo, JY, Alexander, JM, Mclntire, DD, Leveno, KJ. Defining uterine tachysystole: how much is too much?. Am J Obstet Gynecol 2012;207:290e1–6. https://doi.org/10.1016/j.ajog.2012.07.032.Search in Google Scholar PubMed

17. Carroli, G, Cuesta, C, Abalos, E, Gulmezoglu, AM. Epidemiology of postpartum haemorrhage: a systematic review. Best Pract Res Clin Obstet Gynaecol 2008;22:999–1012. https://doi.org/10.1016/j.bpobgyn.2008.08.004.Search in Google Scholar PubMed

18. Higgins, JPT, Thompson, SG, Deeks, JJ, Altman, DJ. Measuring inconsistency in meta-analyses. BMJ 2003;327:557–60. https://doi.org/10.1136/bmj.327.7414.557.Search in Google Scholar PubMed PubMed Central

19. Higgins, JP, Sterne, JA, Savovic, J, Page, MJ, Hróbjartsson, A, Boutron, I, et al. A revised tool for assessing risk of bias in randomized trials. Cochrane Database Syst Rev 2016;10:29–31.Search in Google Scholar

20. Egger, M, Davey Smith, G, Schneider, M, Minder, C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629–34. https://doi.org/10.1136/bmj.315.7109.629.Search in Google Scholar PubMed PubMed Central

21. Terrin, N, Schmid, CH, Lau, J, Olkin, I. Adjusting for publication bias in the presence of heterogeneity. Stat Med 2003;22:2113–26. https://doi.org/10.1002/sim.1461.Search in Google Scholar PubMed

22. Neerukonda, M, More, S, Himabindu, N. High dose oxytocin versus low dose oxytocin for augmentation of labor: a prospective, comparative, randomized study. Int J Med Res Health Sci 2018;7:6–10.Search in Google Scholar

23. Liu, J, Yi, Y, Weiwei, X. Effects of increased frequency, high dose, and pulsatile oxytocin regimens on abnormal labor delivery. Med Sci Monit 2018;24:2063–71. https://doi.org/10.12659/msm.906728.Search in Google Scholar PubMed PubMed Central

24. Merrill, DC, Zlatnik, FJ. Randomized, double-masked comparison of oxytocin dosage in induction and augmentation of labor. Obstet Gynecol 1999;94:455–63. https://doi.org/10.1016/s0029-7844(99)00338-5.Search in Google Scholar

25. Jamal, A, Kalantari, R. High and low dose oxytocin in augmentation of labor. Int J Gynecol Obstet 2004;87:6–8. https://doi.org/10.1016/j.ijgo.2004.06.004.Search in Google Scholar PubMed

26. Bidgood, KA, Steer, PJ. A randomized control study of oxytocin augmentation of labour. 1. Obstetric outcome. Br J Obstet Gynaecol 1987;94:512–7. https://doi.org/10.1111/j.1471-0528.1987.tb03142.x.Search in Google Scholar PubMed

27. Kenyon, S, Armstrong, N, Johnston, T, Walkinshaw, S, Petrou, S, Howman, A, et al. Standard- or high-dose oxytocin for nulliparous women with confirmed delay in labour: quantitative and qualitative results from a pilot randomised controlled trial. BJOG Int J Obstet Gynaecol 2013;120:1403–12. https://doi.org/10.1111/1471-0528.12331.Search in Google Scholar PubMed

28. Wei, S-Q, Luo, Z-C, Qi, H-P, Xu, H, Fraser, WD. High-dose vs low-dose oxytocin for labor augmentation: a systematic review. Am J Obstet Gynecol 2010;203:296–304. https://doi.org/10.1016/j.ajog.2010.03.007.Search in Google Scholar PubMed


Supplementary Material

The online version of this article offers supplementary material (https://doi.org/10.1515/jpm-2020-0042).


Received: 2020-02-05
Accepted: 2020-08-11
Published Online: 2020-09-21
Published in Print: 2021-02-23

© 2020 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 26.4.2024 from https://www.degruyter.com/document/doi/10.1515/jpm-2020-0042/html
Scroll to top button